XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
At-the-market (ATM) Offering
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
At-the-market (ATM) Offering
Common Stock
Class B Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
At-the-market (ATM) Offering
Accumulated Deficit
Balance at Dec. 31, 2023 $ 84,399   $ 5   $ 2 $ 338,114   $ (253,722)
Balance (in shares) at Dec. 31, 2023     56,840,989   15,055,288      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (9,848)             (9,848)
Issuance of restricted stock, net (in shares)     41,007          
Exercise of stock options 55         55    
Exercise of stock options (in shares)     70,670          
Stock-based compensation expense 1,032         1,032    
Balance at Mar. 31, 2024 75,638   $ 5   $ 2 339,201   (263,570)
Balance (in shares) at Mar. 31, 2024     56,952,666   15,055,288      
Balance at Dec. 31, 2023 84,399   $ 5   $ 2 338,114   (253,722)
Balance (in shares) at Dec. 31, 2023     56,840,989   15,055,288      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (20,004)              
Balance at Jun. 30, 2024 66,761   $ 5   $ 2 340,480   (273,726)
Balance (in shares) at Jun. 30, 2024     57,131,702   15,055,288      
Balance at Mar. 31, 2024 75,638   $ 5   $ 2 339,201   (263,570)
Balance (in shares) at Mar. 31, 2024     56,952,666   15,055,288      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (10,156)             (10,156)
Issuance of restricted stock, net (in shares)     34,915          
Exercise of stock options 105         105    
Exercise of stock options (in shares)     144,121          
Stock-based compensation expense 1,174         1,174    
Balance at Jun. 30, 2024 66,761   $ 5   $ 2 340,480   (273,726)
Balance (in shares) at Jun. 30, 2024     57,131,702   15,055,288      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued under "at-the-market" (ATM) Sales Agreement, net (in shares)       1,579,912        
Balance at Jun. 30, 2025 35,126   $ 6   $ 2 348,203   (313,085)
Balance (in shares) at Jun. 30, 2025     63,525,713   15,055,288      
Balance at Dec. 31, 2024 49,040   $ 5   $ 2 343,475   (294,442)
Balance (in shares) at Dec. 31, 2024     58,076,261   15,055,288      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (9,418)             (9,418)
Issuance of restricted stock, net (in shares)     29,135          
Exercise of stock options 33         33    
Exercise of stock options (in shares)     41,390          
Shares issued under "at-the-market" (ATM) Sales Agreement, net   $ 129         $ 129  
Shares issued under "at-the-market" (ATM) Sales Agreement, net (in shares)       126,398        
Issuance of common stock and warrants, net of offering costs 2,385   $ 1     2,384    
Issuance of common stock and warrants, net of offering costs (in shares)     4,511,278          
Issuance of common stock in connection with warrant exercise (in shares)     100          
Stock-based compensation expense 945         945    
Balance at Mar. 31, 2025 43,114   $ 6   $ 2 346,966   (303,860)
Balance (in shares) at Mar. 31, 2025     62,784,562   15,055,288      
Balance at Dec. 31, 2024 49,040   $ 5   $ 2 343,475   (294,442)
Balance (in shares) at Dec. 31, 2024     58,076,261   15,055,288      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (18,643)              
Shares issued under "at-the-market" (ATM) Sales Agreement, net (in shares)       808,191        
Balance at Jun. 30, 2025 35,126   $ 6   $ 2 348,203   (313,085)
Balance (in shares) at Jun. 30, 2025     63,525,713   15,055,288      
Balance at Mar. 31, 2025 43,114   $ 6   $ 2 346,966   (303,860)
Balance (in shares) at Mar. 31, 2025     62,784,562   15,055,288      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (9,225)             (9,225)
Issuance of restricted stock, net (in shares)     26,608          
Exercise of stock options 4         4    
Exercise of stock options (in shares)     32,750          
Shares issued under "at-the-market" (ATM) Sales Agreement, net   $ 686         $ 686  
Shares issued under "at-the-market" (ATM) Sales Agreement, net (in shares)       681,793        
Stock-based compensation expense 547         547    
Balance at Jun. 30, 2025 $ 35,126   $ 6   $ 2 $ 348,203   $ (313,085)
Balance (in shares) at Jun. 30, 2025     63,525,713   15,055,288